Risk factors of primary and recurrent fractures in postmenopausal osteoporotic Chinese patients: A retrospective analysis study.

Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874 (Electronic) Linking ISSN: 14726874 NLM ISO Abbreviation: BMC Womens Health Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2001-

Osteoporosis, Postmenopausal*/complications ; Osteoporosis, Postmenopausal*/epidemiology ; Osteoporotic Fractures*/epidemiology ; Vascular Diseases*/complications; Aged ; Humans ; Female ; Retrospective Studies ; Postmenopause ; Overweight/complications ; China/epidemiology ; Risk Factors

Background: As postmenopausal osteoporotic fractures can cause higher rates of disability and mortality in women; it is essential to analyze the factors associated with primary and recurrent fractures in postmenopausal osteoporosis (PMOP) patients.
Methods: Retrospective analysis of 2478 PMOP patients aged ≥ 50 years who attended the Shanghai General Hospital from January 2007 to December 2016, including 1239 patients with no fractures and 1239 patients with histories of fractures (1008 in the primary fracture group and 231 in the re-fracture group). All patients' basic clinical data, serum biochemical and bone metabolic markers, bone mineral density (BMD), and other indicators were recorded uniformly. Comparing the differences between the clinical characteristics of patients with primary and recurrent fractures, as well as the differences in the clinical characteristics of patients with primary and recurrent fractures in combination with different diseases, further analyses the risk factors for primary and recurrent fractures in PMOP patients. SPSS.26 was used for statistical analysis.
Results: Compared to the unfractured group, the fractured group was older and had lower height and bone mineral density (all P < 0.01), with the re-fractured group having lower BMD at each key site than the primary fracture group (all P < 0.01). Analysis of the combined disease subgroups showed that serum BGP levels were lower in the primary and re-fracture patients with diabetes than in the non-diabetic subgroup (P < 0.05), and serum CTX levels were lower in the re-fracture group with diabetes than in the primary fracture group with diabetes (P < 0.05). Patients with recurrent fractures with cardio-vascular diseases had lower BMD than the subgroup without cardio-vascular diseases (P < 0.05) and also had lower BMD than the group with primary fractures with cardio-vascular diseases (P < 0.05). Multiple logistic regression analysis showed that advanced age, overweight, low lumbar spine and total hip BMD were risk factors for primary and recurrent fractures; and comorbid chronic liver and kidney diseases were risk factors for primary fractures.
Conclusion: PMOP patients with advanced age, overweight, low bone mineral density, and comorbid chronic liver and kidney diseases are at greater risk of fractures and require early intervention to reduce fractures occurrence. Moreover, those who are elderly, overweight, and have low bone density should also be aware of the risk of re-fractures.
(© 2022. The Author(s).)

Bone. 2017 Dec;105:287-291. (PMID: 28842362)
JAMA. 2009 Feb 4;301(5):513-21. (PMID: 19190316)
Curr Opin Rheumatol. 2015 Jul;27(4):414-9. (PMID: 26002034)
Orthop Surg. 2021 Jun;13(4):1205-1212. (PMID: 33942553)
Orthop Surg. 2020 Feb;12(1):194-198. (PMID: 31943831)
Adv Clin Chem. 2021;105:101-140. (PMID: 34809826)
Osteoporos Int. 2007 Apr;18(4):505-12. (PMID: 17109061)
J Diabetes Res. 2020 May 22;2020:7608964. (PMID: 32566682)
Calcif Tissue Int. 2019 Jun;104(6):599-604. (PMID: 30680432)
Osteoporos Int. 2017 May;28(5):1641-1652. (PMID: 28220196)
Arch Gynecol Obstet. 2021 Sep;304(3):703-712. (PMID: 34247254)
Arch Osteoporos. 2018 Mar 3;13(1):15. (PMID: 29502187)
Osteoporos Int. 2019 Jan;30(1):79-92. (PMID: 30456571)
Injury. 2019 Aug;50(8):1423-1428. (PMID: 31256910)
Endocr Pract. 2020 May;26(Suppl 1):1-46. (PMID: 32427503)
Endocrinol Metab (Seoul). 2021 Dec;36(6):1178-1188. (PMID: 34915604)
J Bone Metab. 2019 Nov;26(4):263-270. (PMID: 31832392)
Osteoporos Int. 2016 Jan;27(1):387-96. (PMID: 26576544)
Pain Physician. 2021 May;24(3):E335-E340. (PMID: 33988955)
JAMA Intern Med. 2021 Aug 1;181(8):1055-1063. (PMID: 34096979)
Osteoporos Int. 2021 Apr;32(4):769-777. (PMID: 33095419)
Osteoporos Int. 2020 Nov;31(11):2103-2111. (PMID: 32613410)
Endocr J. 2017 Nov 29;64(11):1043-1053. (PMID: 28966224)
Int J Mol Sci. 2019 Aug 31;20(17):. (PMID: 31480433)
Osteoporos Int. 2013 Jan;24(1):69-76. (PMID: 23229467)
Diabetes Metab Res Rev. 2019 Jan;35(1):e3069. (PMID: 30144272)
Osteoporos Int. 2005 Nov;16(11):1330-8. (PMID: 15928804)
Arch Osteoporos. 2020 Nov 13;15(1):180. (PMID: 33188505)
J Bone Miner Res. 2004 Mar;19(3):386-93. (PMID: 15040826)
Clin Chim Acta. 2018 Feb;477:135-140. (PMID: 29246667)
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1197-208. (PMID: 23825036)
BMC Med. 2006 Oct 09;4:24. (PMID: 17029622)
Liver Int. 2018 May;38(5):776-785. (PMID: 29479832)
Osteoporos Int. 2019 Sep;30(9):1755-1765. (PMID: 31227885)
Osteoporos Int. 2013 Feb;24(2):511-21. (PMID: 22588182)
JBMR Plus. 2019 Oct 29;3(12):e10238. (PMID: 31844826)
Nutrients. 2020 Jan 13;12(1):. (PMID: 31941004)
Orthop Surg. 2020 Feb;12(1):116-123. (PMID: 31880071)
Int J Mol Sci. 2020 Nov 26;21(23):. (PMID: 33256181)
J Bone Miner Res. 2013 Nov;28(11):2317-24. (PMID: 23616397)
Int J Mol Sci. 2020 Sep 18;21(18):. (PMID: 32961953)

Keywords: Bone metabolism markers; Bone mineral density; Postmenopausal osteoporosis; Primary fractures; Recurrent fractures; Risk factors

Date Created: 20221120 Date Completed: 20221122 Latest Revision: 20221213

20221213

PMC9677643

10.1186/s12905-022-02034-z

36404305